Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Brain Metastases
Related studies linked through entity extraction aliases.
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
- Status
- RECRUITING
- Phase
- PHASE2
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
- Status
- RECRUITING
- Phase
- PHASE2
Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases
- Status
- RECRUITING
- Phase
- N/A
Combination of Local Therapy and Target Therapy for Brain Metastases With EGFR Mutation
- Status
- UNKNOWN
- Phase
- N/A
Treatments for Brain Metastases With Poor Prognostic Factors
- Status
- UNKNOWN
- Phase
- N/A
Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Evaluation of Clinical Decision Support System for Brain Metastasis Using Brain MR Images
- Status
- UNKNOWN
- Phase
- NA
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- Status
- RECRUITING
- Phase
- N/A
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
- Status
- RECRUITING
- Phase
- PHASE2
Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess the Efficacy of Cerebellar IMRT Combined With Cerebral SRS in Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- NA
Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)
- Status
- COMPLETED
- Phase
- PHASE2
Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI
- Status
- RECRUITING
- Phase
- NA
Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastases
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
- Status
- RECRUITING
- Phase
- PHASE2
The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?
- Status
- RECRUITING
- Phase
- NA